India May Have Concerns on DowDuPont

(c) Dow Chemicals
(c) Dow Chemicals

Just as news agencies and the CEOs of and DuPont had begun reporting that the merger of the two US chemical powerhouses was close to receiving all regulatory approvals, antitrust authorities in India have announcd they have concerns about the $130 billion deal.

In a statement on Mar. 22, the Competition Commission of India (CCI) said it is “of the prima facie opinion that the proposed combination between Dow Chemical Company and E. I. du Pont de Nemours and Company is likely to have an appreciable adverse effect on competition."

The authority has not been explicit about its concerns but said it has sought public opinion on the deal and has directed the two companies to publish details of their proposed merger.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.